NGM Biopharmaceuticals, Inc. (NGM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 70.86M |
| Enterprise Value | 12.05M |
| P/E Ratio | -0.89 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 29.1 |
| Price/Book Ratio | 0.85 |
| Enterprise/Revenue | 15.78 |
| Enterprise/EBITDA | -0.48 |
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | December 31, 2023 |
| Profit Margin | -32.23 |
| Operating Margin | -33.18 |
| Return On Assets | -0.84 |
| Return On Equity | -0.7 |
| Revenue | 4.42M |
| Revenue/Share | 0.05 |
| Gross Profit | 2.2M |
| EBITDA | -144.33M |
| Net Income | -142.38M |
| Diluted EPS | -1.73 |
| Total Cash | 147.18M |
| Total Cash/Share | 1.78 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 7.79 |
| Book Value Per Share | 1.8 |
| 52-Week Change | -60.91 |
| 52-Week High | 4.69 |
| 52-Week Low | 0.6 |
| Moving Average 50 Days | 1.55 |
| Moving Average 200 Days | 1.49 |
| Average Volume | 1.07M |
| Shares Outstanding | 83.46M |
| % Held by Institutions | 41.82 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |